Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Buspirone and mirtazapine for functional dyspepsia with postprandial distress symptoms
IRCT20210724051972N1Phase 3Completed
- Sponsor
- Vice Chancellor for Research, Birjand University of Medical Sciences
- Start
- Nov 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, single-blind trial of buspirone and mirtazapine in functional dyspepsia (FD) (3 arms), sponsored by Vice Chancellor for Research, Birjand University of Medical Sciences. Primary endpoints: Functional dyspepsia, Severity of anxiety and 1 more. Started Nov 2021; status: completed.
02
Drugs
buspironemirtazapine
03
Conditions
functional dyspepsia (FD)
Beyond the preview
Go deeper on IRCT20210724051972N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20210724051972N1.